Mechanisms for thrombolysis-induced increases in procoagulant and proinflammatory activity

Fibrinolysis and Proteolysis

Volumn 11, Issue SUPPL. 1, 1997, Pages 115-118

  Schaiff, W T ^a   Eisenberg, P R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; FIBRINOLYTIC AGENT; FIBRINOPEPTIDE A; HEPARIN; HIRUDIN; HIRULOG; INTERCELLULAR ADHESION MOLECULE 1; PLASMIN; PLASMINOGEN; PROCOAGULANT; STREPTOKINASE; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE HEART INFARCTION; BLOOD CLOTTING; CLINICAL TRIAL; COMPLEMENT ACTIVATION; CONFERENCE PAPER; DRUG MECHANISM; FIBRINOLYTIC THERAPY; HUMAN; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE ACTIVATION; NEUTROPHIL CHEMOTAXIS; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; REPERFUSION INJURY; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOSIS; TREATMENT OUTCOME;

EID: 0030697244     PISSN: 13690191     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-9499(97)80034-3     Document Type: Conference Paper

References (16)

1. The GUSTO angiographic investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993; 329: 1615-1622.
2. Lucchesi B R. Complement activation, neutrophils, and oxygen radicals in reperfusion injury. Stroke 1993; 24: 138-40.
3. Schaiff W T, Eisenberg P R. Direct induction of complement activation by pharmacologic activation of plasminogen. Coron Artery Dis 1997; in press.
4. Ewald G A, Eisenberg P R. Plasmin-mediated activation of the contact system in response to pharmacologic thrombolysis. Circulation 1995; 91: 28-36.
5. Eisenberg P R, Sobel B E, Jaffe A S. Activation of prothrombin accompanying thrombolysis with rt-PA. J Am Coll Cardiol 1992; 19: 1065-1069.
6. Eisenberg P R, Sherman L A, Jaffe A S. Paradoxic elevation of fibrinopeptide A: Evidence for continued thrombosis despite intensive fibrinolysis. J Am Coll Cardiol 1987; 10: 527-529.
7. Eisenberg P R. Novel antithrombotic strategies for the treatment of coronary artery thrombosis: A critical appraisal. J Thromb Thrombolysis 1995; 1: 237-250.
8. Scharfstein J S, Abendschein D R, Eisenberg P R, George D, Cannon C P, Becker R C, Sobel B, Cupples L A, Braunwald E, Loscalzo J. Usefulness of fibrinogenolytic and procoagulant markers during thrombolytic therapy in predicting clinical outcomes in acute myocardial infarction. Am J Cardiol 1996; 78: 503-510.
9. Antman E M. Hirudin In Acute Myocardial Infarction - Thrombolysis and Thrombin Inhibition In Myocardial Infarction (Timi) 9b Trial. Circulation 1996; 94: 911-921.
10. Eisenberg P R, Miletich J P. Induction of marked thrombin activity by pharmacologic concentrations of plasminogen activators in nonanticoagulated whole blood. Thromb Res 1989; 55: 635-643.
11. Lee C D, Mann K G. The activation of human coagulation factor V by plasmin. Blood 1989; 73: 185-190.
12. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Eng J Med 1993; 329: 673-682.
13. Galvani M, Abendschein D R, Ferrini D, Ottani F, Rusticali F, Eisenberg P R. Failure of fixed dose intravenous heparin to suppress increases in thrombin activity after coronary thrombolysis with streptokinase. J Am Coll Cardiol 1994; 24: 1445-1551.
14. Bajzar L, Morser J, Nesheim M. TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. J Biol Chem 1996; 271: 16603-16608.
15. Agostoni A, Gardinali M, Frangi D, Cafaro C, Conciato L, Sponzilli C, Salvioni A, Cugno M, Cicardi M. Activation of complement and kinin systems after thrombolytic therapy in patients with acute myocardial infarction. A comparison between streptokinase and recombinant tissue-type plasminogen activator. Circulation 1994; 90: 2666-2670.
16. Schaiff W T, Iademarco M F, Eisenberg P R, Schwartz D. Thrombin-stimulated VCAM-1 expression by cultured human vascular endothelial cells: Interleukin-4 induced synergistic response. Manuscript submitted 1997.